REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection

Previous studies have demonstrated that REBACIN(®) intervention eliminates persistent high-risk human papillomavirus (hrHPV) infection. The initial establishment and subsequent progression of cervical cancer mainly depends on two major oncogenes, E6/E7, and previous studies have proposed E6/E7 oncog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shu-Guang, Wu, Dai-Fei, Yao, Hui, Zhang, Wei-Yu, Tian, Feng-Jiao, Chen, Guo, Zhang, Chun-Fa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763439/
https://www.ncbi.nlm.nih.gov/pubmed/36561517
http://dx.doi.org/10.3389/fonc.2022.1047222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763439/
https://www.ncbi.nlm.nih.gov/pubmed/36561517
http://dx.doi.org/10.3389/fonc.2022.1047222

Ejemplares similares